Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2023 - IJCMAS--ICV 2023: 95.56 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 15, Issue:2, February, 2026

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2026.15(2): 128-137
DOI: https://doi.org/10.20546/ijcmas.2026.1502.012


Cervical cancer screening - comparison between molecular assay to detect Human Papilloma Virus (HPV) DNA genotype and cytology examination from LBC samples in a Reference Laboratory in East India
Jayitri Das (Jt. 1st author)1, Swatilekha Banerjee (Jt. 1st author)1, Sumedha Dey1, Himadri Mondal1, Zishan Akhter1, Reena Nakra2, Vandana Lal2 and Mallika Ghosh1*
1Dr. Lal PathLabs Ltd., Kolkata Reference Lab, India 2Dr. Lal PathLabs Ltd., National Reference Lab, India
*Corresponding author
Abstract:

Cervical cancer is a public health problem in developing countries like India, so much so that India alone accounts for one-quarter of the worldwide burden of cervical cancers; and Human papilloma virus (HPV) is the most common causative factor. 30 different strains of HPV is associated with high risk for cervical cancer. The premise of our descriptive prospective study is based on the above context and compares HPV genotype prevalence with cytological findings. Cervical samples were collected in Eziprep liquid based cytology vials from 1009 patients from East/ North East India. HPV DNA genotyping was done using automated platform of QiaSymphony SP and cytology smears were made using Eziprep Nanocyt machine which uses Thin prep type LBC method. Commonest genotypes detected were 16 and 52, both of which were high risk genotypes. Cases with multiple infections also had at least one high risk genotype. 17 showed epithelial abnormality and most common type was atypical squamous cell of uncertain significance (ASCUS) followed by Atypical squamous cell cannot rule out high grade lesion (ASC-H). Most common genotypes associated with epithelial abnormalities were 16 followed by 58 and 59. 3 cases were identified with HPV negative epithelial abnormality. HPV 16 was found to be most common high risk genotype. Contrary to literature, 2nd most common genotype was not found to be HPV 18. HPV 52 was overall 2nd most common genotype while 58 and 59 were 2nd most common genotypes associated with epithelial abnormality.


Keywords: Human Papilloma Virus (HPV), Liquid based cytology, High risk genotype, ASCUS, Cervical cancer screening


References:

Aggarwal, R. et al., 2006. Prevalence of high-risk human papillomavirus infections in women with benign cervical cytology: a hospital based study from North India. Indian Journal of Cancer, 43(3), pp.110–116. https://doi.org/10.4103/0019-509X.27937

Bao, Y.P., Li, N., Smith, J.S. and Qiao, Y.L. (2008). Human papillomavirus type distribution in women from Asia: a meta-analysis. International Journal of Gynecological Cancer, 18(1), pp.71–79. https://doi.org/10.1111/j.1525-1438.2007.01011.x

Bhatla, N et al., 2021. Cervical cancer prevention efforts in India. Indian Journal of Gynecologic Oncology, 19(3), p.41. https://doi.org/10.1007/s40944-021-00550-9

Bruni, L et al., 2010. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. Journal of Infectious Diseases, 202(12), pp.1789–1799. https://doi.org/10.1086/657321

Bruni, L. et al., 2019. Human Papillomavirus and Related Diseases in the World: Summary Report 17 June 2019.

Burd, E.M. (2003). Human papillomavirus and cervical cancer. Clinical Microbiology Reviews, 16(1), pp.1–17. https://doi.org/10.1128/CMR.16.1.1-17.2003

Chen, X. et al., 2017. ‘Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015’, Scientific Reports, 7(1), 14813. https://doi.org/10.1038/s41598-017-14913-7

Datta, P. et al., 2010. Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiology, 34(2), pp.157–161. https://doi.org/10.1016/j.canep.2009.12.006

Ferlay, J. et al., 2012. GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide in 2012. Lyon, France: International Agency for Research on Cancer.

Franceschi, S. et al., 2005. Papillomavirus infection in rural women in southern India. British Journal of Cancer, 92(3), pp.601–606. https://doi.org/10.1038/sj.bjc.6602404

Giannella, L. et al., 2022. HPV-Negative Adenocarcinomas of the Uterine Cervix: From Molecular Characterization to Clinical Implications. International Journal of Molecular Sciences, 23(23), p.15022. https://doi.org/10.3390/ijms232315022

Goodman, M.T. et al., 2008. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Research, 68, pp.8813–8824. https://doi.org/10.1158/0008-5472.CAN-08-1380

Gopika, M.G., Prabhu, P.R. and Thulaseedharan, J.V. (2022). Status of cancer screening in India: An alarm signal from the National Family Health Survey (NFHS 5). Journal of Family Medicine and Primary Care, 11, pp.7303–7307. https://doi.org/10.4103/jfmpc.jfmpc_1459_22

Institute for Health Metrics and Evaluation (2011). The Challenge Ahead: Progress in Breast and Cervical Cancer. Seattle: IHME.    

Kerkar, S.C. et al., 2011. Human Papillomavirus infection in asymptomatic population. Sexual & Reproductive Healthcare, 2(1), pp.7–11. https://doi.org/10.1016/j.srhc.2010.10.003

Liu, F. et al., 2021. ‘Association of human papillomavirus genotype distribution and cervical cytology: a cross-sectional study’, Epidemiology and Infection, 149, e95. https://doi.org/10.1017/S0950268821000887

Louvanto, K. et al., 2010. Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study. Journal of Clinical Microbiology, 48(8), pp.2665–2671. https://doi.org/10.1128/JCM.00373-10

Molijn, A. et al., 2016. The complex relationship between human papillomavirus and cervical adenocarcinoma. International Journal of Cancer, 138(2), pp.409–416. https://doi.org/10.1002/ijc.29705

Munjal, K. et al., 2014. Human papillomavirus type distribution in invasive cervical cancers from Madhya Pradesh: implications for vaccination programs in central India. International Journal of Gynecological Pathology, 33(5), pp.531–536. https://doi.org/10.1097/PGP.0000000000000126

Muwonge, R. et al., 2020. Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.

Nayar, R. and Wilbur, D.C. (2015). The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes. 3rd edn. Switzerland: Springer International Publishing.

Okunade, K.S. (2020). Human Papilloma Virus and Cervical cancer. Journal of Obstetrics and Gynaecology, 40(5), pp.602–608. https://doi.org/10.1080/01443615.2019.1634030

Pillai, R.M. et al., 2010. Region-wide distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India. International Journal of Gynecological Cancer, 20(6), pp.1046–1051.https://doi.org/10.1111/IGC.0b013e3181e02dce

Richardson, H. et al., 2003. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiology, Biomarkers & Prevention, 12, pp.485–490. https://doi.org/10.1158/1055-9965.EPI-02-0819

Rosa, M.I. et al., 2008. Persistence and clearance of human papillomavirus infection: a prospective cohort study. American Journal of Obstetrics and Gynecology, 199, pp.617.e1–e7. https://doi.org/10.1016/j.ajog.2008.07.021

Sathawane, P. et al., 2022. Nuances of the Papanicolaou stain. CytoJournal, 19, p.43. https://doi.org/10.25259/Cytojournal_24_2022

Sellors, J.W. et al., 2003. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ, 168, pp.421–425. https://doi.org/10.1503/cmaj.1020871

Senapati, R. et al., 2017. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India. BMC Infectious Diseases, 17(1), p.30. https://doi.org/10.1186/s12879-016-2129-5

Sharma, K. et al., 2015. Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle. PLoS ONE, 10(5), e0125693. https://doi.org/10.1371/journal.pone.0125693

Srivastava, S. et al., 2014. Distribution of HPV Genotypes and involvement of risk factors in cervical lesions and invasive cervical cancer: a study in an Indian population. International Journal of Molecular and Cellular Medicine, 3(2), pp.74–83. https://doi.org/10.22088/IJMCM.BUMS.3.2.74

Srivastava, S., Gupta, S. and Roy, J.K. (2012). High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study. Journal of Biosciences, 37(1), pp.63–72. https://doi.org/10.1007/s12038-011-9177-0

The George Institute for Global Health India (2023). Cervical cancer in India: Challenges and opportunities. [Online] The George Institute for Global Health. 

Varghese, C. (2000). Prevalence and determinants of human papillomavirus (HPV) infection in Kerala, India. PhD thesis. University of Tampere.

Vinodhini, K. et al., 2012. Prevalence of high-risk HPV and associated risk factors in cases of cervical carcinoma in Tamil Nadu, India. International Journal of Gynaecology and Obstetrics, 119(3), pp.253–256. https://doi.org/10.1016/j.ijgo.2012.07.005

Walboomers, J.M. et al., 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189, pp.12–19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1

World Health Organization (WHO) (2021). Guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd edn. Geneva: WHO. 

World Health Organization (WHO) (n.d.). Fact sheet on cervical cancer. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer  

Download this article as Download

How to cite this article:

Jayitri Das, Swatilekha Banerjee, Sumedha Dey, Himadri Mondal, Zishan Akhter, Reena Nakra, Vandana Lal and Mallika Ghosh. 2026. Cervical cancer screening - comparison between molecular assay to detect Human Papilloma Virus (HPV) DNA genotype and cytology examination from LBC samples in a Reference Laboratory in East India.Int.J.Curr.Microbiol.App.Sci. 15(2): 128-137. doi: https://doi.org/10.20546/ijcmas.2026.1502.012
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations